肥胖和2型糖尿病中C57BL/6小鼠与人类的IgM相关肠道细菌
研究用仅分泌IgM的Aid-/- B6小鼠及肥胖青少年粪便移植无菌B6小鼠,发现Aid-/-小鼠高脂饮食诱导肥胖加重,2型糖尿病肥胖青少年IgM结合肠道细菌更多,其粪便移植可致受体鼠体重增加和糖耐量受损。
要点
- Aid-/- B6小鼠因IgM水平丰富,高脂饮食诱导肥胖较野生型小鼠加重。
- 肥胖2型糖尿病青少年肠道中IgM结合的细菌更多。
- 其粪便移植可致无菌B6小鼠体重增加和糖耐量受损。
核心结论
- IgM结合的肠道菌群可能在肥胖和2型糖尿病的免疫发病机制中起重要作用,并在小鼠和人类中提供IgM与肥胖和2型糖尿病之间的新联系。
研究设计与样本
- 研究使用仅分泌IgM抗体的Aid-/-(亦称Aicda-/-)B6小鼠与野生型小鼠比较高脂饮食诱导肥胖的免疫代谢效应和肠道微生物变化。
- 收集肥胖且糖耐量正常、肥胖且糖耐量受损、肥胖且新诊断2型糖尿病的儿童和青少年粪便样本,移植入无菌B6小鼠,评估IgM结合细菌和免疫反应。
主要发现
- 与野生型小鼠相比,Aid-/- B6小鼠因IgM水平丰富而高脂饮食诱导肥胖加重。
- 将Aid-/- B6小鼠粪便移植给无菌B6小鼠,较野生型小鼠粪便移植促使受体鼠体重增加更多。
- 肥胖2型糖尿病青少年有更多IgM结合的肠道细菌。
- 用肥胖2型糖尿病青少年粪便移植给无菌B6小鼠,其肠道菌群促使受体鼠体重增加并损害糖耐量。
- 这些肥胖年轻个体的一些临床特征在粪便移植后的无菌B6小鼠中得以重现。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: IgM is the primary antibody produced by B cells and we hypothesise that IgM antibodies to gut microbiota may play a role in immunometabolism in obesity and type 2 diabetes. To test our hypothesis, we used B6 mice deficient in activation-induced cytidine deaminase (Aid-/- [also known as Aicda-/-]) which secrete only IgM antibodies, and human faecal samples. METHODS: We studied the immunometabolic effects and gut microbial changes in high-fat-diet-induced obesity (HFDIO) in Aid-/- B6 mice compared with wild-type mice. To determine similarities between mice and humans, human stool samples were collected from children and adolescents who were obese with normal glucose tolerance (NGT), obese with glucose intolerance (IGT), or obese and newly diagnosed with type 2 diabetes, for faecal microbiota transplant (FMT) into germ-free (GF) B6 mice and we assessed IgM-bound bacteria and immune responses. RESULTS: Compared with wild-type mice, Aid-/- B6 mice developed exacerbated HFDIO due to abundant levels of IgM. FMT from Aid-/- B6 to GF B6 mice promoted greater weight gain in recipient mice compared with FMT using wild-type mouse faecal microbiota. Obese youth with type 2 diabetes had more IgM-bound gut bacteria. Using the stools from the obese youth with type 2 diabetes for FMT to GF B6 mice, we observed that the gut microbiota promoted body weight gain and impaired glucose tolerance in the recipient GF B6 mice. Importantly, some clinical features of these obese young individuals were mirrored in the GF B6 mice following FMT. CONCLUSIONS/INTERPRETATION: Our results suggest that IgM-bound gut microbiota may play an important role in the immuno-pathogenesis of obesity and type 2 diabetes, and provide a novel link between IgM in obesity and type 2 diabetes in both mice and humans. DATA AVAILABILITY: The 16s rRNA sequencing datasets supporting the current study have been deposited in the NCBI SRA public repository ( https://www.ncbi.nlm.nih.gov/sra ; accession no. SAMN18796639).
引用
- Pearson JA, Ding H, Hu C, et al. IgM-associated gut bacteria in obesity and type 2 diabetes in C57BL/6 mice and humans. Diabetologia. 2022. PMID: 35587276. doi:10.1007/s00125-022-05711-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。